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Gut microbiota is established during birth and evolves with age, mostly maintaining the commensal relationship with the host.
A growing body of clinical evidence suggests an intricate relationship between the gut microbiota and the immune system. With
ageing, the gutmicrobiota develops significant imbalances in themajor phyla such as the anaerobic Firmicutes and Bacteroidetes as
well as a diverse range of facultative organisms, resulting in impaired immune responses. Antimicrobial therapy is commonly used
for the treatment of infections; however, this may also result in the loss of normal gut flora. Advanced age, antibiotic use, underlying
diseases, infections, hormonal differences, circadian rhythm, and malnutrition, either alone or in combination, contribute to the
problem. This nonbeneficial gastrointestinal modulation may be reversed by judicious and controlled use of antibiotics and the
appropriate use of prebiotics and probiotics. In certain persistent, recurrent settings, the option of faecal microbiota transplantation
can be explored. The aim of the current review is to focus on the establishment and alteration of gut microbiota, with ageing. The
review also discusses the potential role of gut microbiota in regulating the immune system, together with its function in healthy
and diseased state.
1. Introduction
The human body contains a diverse range of bacterial
species, with lesser representation from viral and eukaryotic
microbes, that have been referred to as a “microbial bank.”
As the human gut harbors most of the microbes, it can be
considered as a “microbial organ.” All themicrobes in the gut
are collectively known as “gutmicrobiota” and genomes asso-
ciate with them represent the “gut microbiome.” Previously,
the bacterial count in a healthy adult was estimated to be 1014
to 1015 cells. However, recently revised [1], the bacterial load
in a healthy adult (using volume and mass as variables) was
estimated to be approximately 3× 1013 bacterial cells in a 70 kg
adult. The microbiota is not a homogenous population of
microorganisms; rather, it is comprised of an intricate range
ofmicrobial communities that interact with each other aswell
as with the host, in a way that impacts the health of the host
[2]. The Bacteroidetes and Firmicutes are the major bacte-
rial phyla, with subgroups like Fusobacteria, Cyanobacteria,
Proteobacteria, Verrucomicrobia, Actinobacteria, and a few
others.
A healthy intestinal tract is relatively stable throughout
the adulthood, but with the ageing process, perturbations
occur with exogenous factors such as antibiotics use and diet
and endogenous factors like cellular stress. Ageing and related
complications are leading public health concerns worldwide
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[3]. Ageing is accompanied by major physiological changes
such as alteration in the gut microbial composition (dysbio-
sis), immune responses, and metabolism which may lead to
various gastrointestinal (GI) tract related inflammatory con-
ditions, and autoimmune disorders [4, 5].Theusual threshold
age for defining older adults or elderly is above 63–76 years,
and around this age the gut microbiota loses its relative
stability [6, 7]. Any compositional differences with ageing
have a direct effect on the intestinal motility and digestion
[8]. Fermentation processes in the colonic gut are altered
adversely with variations in the microbiota. This affects
the homeostasis in the gut, leading to immunosenescence
(decline in immune responses) and inflamm-ageing, that
is, low-grade inflammatory response [9–11]. In the present
review, we focus on the establishment and alteration of gut
microbiota with ageing. Moreover, the review also discusses
the potential role of microbiota in regulating the immune
system, and its function in healthy and diseased state.
2. Microbiota and Ageing
2.1. Infancy. The sterile period (in the human life cycle) is
during the gestation, where the fetus grows in the uterus and
remains tolerant tomaternal antigens. However, a few studies
have confirmed the presence of some bacteria in the amniotic
fluid in the uterus, but the number and diversity were found
too low to show any effect on infant gut colonization [2, 12].
The initial colonization on the skin from environmental
organisms takes place immediately after delivery, followed by
gut colonization influenced by maternal and dietary factors.
The nature and extent of neonatal colonization are also
influenced by the method of delivery, whether vaginal or via
the use of instrumental procedures (Figure 1). During vaginal
delivery, studies demonstrated the presence of Lactobacillus,
followed by Prevotella and Sneathia species [2, 23, 24]. After
a caesarean section (C-section), Staphylococcus, Propioni-
bacterium, and Corynebacterium species and high numbers
of Clostridium difficile and Escherichia coli were found in
abundance in the gut compared to infants delivered vaginally
[25, 26].
The possible basis of the bacterial communities establish-
ment in the gut has been described in a study [24] where
they followed two healthy infants from birth for 10 months.
Screening using faecal samples and polymerase chain reac-
tion and denaturing gradient gel electrophoresis (PCR-
DGGE) identified Streptococcus thermophiles, Ruminococcus
gnavus, and Enterococcus raffinosus predominantly through-
out the study. In the 3rd and 4th day faecal samples,
there was rapid colonization with bifidobacterial species
which remained strong for 3 months in both the infants.
Beyond 3months, Clostridium species colonized dominantly,
which contradicted the culture-based theory. According to
the culture-based evidence, Enterobacterium (gram positive)
was the first colonizer, which created and maintained the
stable environment for Bacteroidetes, Bifidobacterium, and
Clostridium to grow in infants. However, the research, either
culture-dependent or independent, explains that the gut colo-
nization in infants exhibits low diversity, instability, and high
dynamics [27, 28]. These experiments were conducted using
DNA from faecal samples of 13 infants 1 month, 3 months,
and 7 months old, which indicated the gut microbiota is
stable over this time frame, though there was interindividual
variability [29]. Antibiotics administration has an influence
on infant gut colonization. Infants who were administered
with antibiotics have lower proportions of lactic acid bacteria
and enterococci [1].
Besides antibiotics use, diet is also known to play a major
role in the gut microbial colonization. The gut of infants
who were breast-fed predominantly comprised streptococci,
bifidobacteria, and E. coli. Enterobacteria and Bacteroides
were common in the gut of infants who were formula-fed
[30]. Changes occur to gut colonization after introduction
of solid foods. A study compared the influence of diet on
the gut microbiota in children (1 to 6 years) who consumed
the Western diet and compared to African diet (fibre-
rich intake). After the Western diet, children had reduced
microbial diversity with lower levels of Actinobacteria and
Bacteroidetes compared to African diet.
2.2. Immunity and Initial Colonization. Themucosal immune
system and gut microbiota coevolve with age. A few studies
indicate that the development of innate and adaptive immune
systems require microbial interactions during infancy [31,
32]. A study also suggested the role of delivery mode in the
development of immunological functions and gutmicrobiota
[33]. This study revealed that infants born by C-section have
relatively higher levels of immunoglobulins produced by
peripheral blood components compared to infants born by
vaginal delivery. Immunoglobulin A (IgA) is mainly secreted
by the gut mucosal layer which contributes to gut barrier
function. IgA elicits low-grade immune responses allowing
bacteria to colonize in the gut [34]. The corelation between
immunoglobulins and gut microbiota development in gno-
tobiotic mice was investigated by Planer et al. [35]. Briefly,
to determine age-related differences in IgA response, donor
microbiota (infants) was introduced into mice, and mice
faecal samples were collected. Interestingly, the IgA responses
were similar to those of the infant donor population. This
study can be used as an indicator for understanding the gut
mucosal immunity andmicrobiota in health and disease. IgA
plays a major role in mucosal immunity, as it is induced in
response to colonization by specific commensal bacteria to
protect the mucosal surfaces and contributes to the host-
microbiota mutualism.
2.3. Childhood, Preadolescence, and Adulthood. In early
childhood (between 1 and 5 years), the expansion of bac-
terial diversity slows down, and the gut microbial diversity
remains lower compared to adults. The gut microbiota in
childhood is more stable and dominated by multiple mem-
bers of Bacteroidetes. In the healthy preadolescence (7 to
12 years), the gut microbiome is species rich, containing
many bacterial taxa and functional genes similar to adult
microbiota enriched with Lachnospiraceae, Anaerovorax,
Bifidobacterium, and Faecalibacterium. The bacterial compo-
sition in adults is predominantly comprised of Bacteroidetes
and Firmicutes (Figure 1). It has been shown that the relative
abundance of both Bacteroidetes and Firmicutes can vary
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Figure 1:Overview of development of microbiota.The gastrointestinal tract (GI) is most sterile during the in utero stage.The first colonization
happens based on mode of delivery either C-section or natural (vaginal delivery). Corynebacterium sp. is thought to be early colonizers in C-
section and Lactobacillus sp. in the vaginal delivery. As the time progress the commensal bacterial community grows and is influenced by the
solid food intake. During the initial stages of microbiota establishment the TLR receptor actions areminimal allowing growth of commensals.
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of birth. The relative stability is attained at the adulthood with Bacteroidetes and Firmicutes dominating. The alteration happens with use of
antibiotics, obesity, GI orders, and diet. During elderly the relative stability declines, commensal community reduces, and pathogenic species
like Clostridium increases. Malnutrition, alcohol abuse, decline in metabolism, frequent hospitalization, nosocomial infections (Clostridium
difficile), and other pathogenic infections leading to Polypharmacy and ultimately to various inflammatory diseases.
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between 0 and 99% [2, 36]. Other groups of researchers
reported the presence of bacteria from phyla Proteobacteria,
Actinobacteria, Fusobacteria Cyanobacteria, andVerrucomi-
crobia, as well as methanogenic archaea, multiple phages
and Eucarya in healthy individuals [14, 37–39]. At phyla
level, the gut microbiota in adults is stable as compared to
infants; however, there is a significant variation in specific
microbial species and their proportions. There is no detailed
study demonstratingmicrobial composition of healthy adults
due to vast interindividual variation in composition. This
variation can be linked to environmental factors shaping
microbiota immediately after birth and low temporal varia-
tion and also due to genetic variation. A holistic approach
to identify conserved and similarities among healthy adults
by proposing the presence of enterotypes such as Bacteroides
(enterotype I), Prevotella (enterotype II), and Ruminococcus
(enterotype III) [26]. They have been shown to remain
relatively stable for around 6 months and evidence of fluctu-
ations between enterotypes was revealed in a 10-year follow-
up study [40]. Despite taxonomic variability, the functional
properties of the adult gutmicrobiota are relatively consistent
with pathways involving metabolism and fermentation. In
older adults, the gut microbiota becomes less diverse and
unstable due to coexisting conditions and age-related factors.
2.4.OlderAdults. Imahori (1992) described ageing as “regres-
sion in physiological functions followed by advancement in
age” [41]. Conventionally, people of age 65 years and above
are termed as older adults by chronological measurement [7,
42, 43]. Understanding gut microbiota and its modulations
is an essential factor in improving the health and the well-
being of older individuals. Perturbations in the gut microbial
composition are associated with chronic conditions such
as obesity and inflammatory diseases. The interindividual
variability is much higher in the older adults than in adults or
infants.There is a significant dysbiosis in gut microbiota with
age, together with the use of antibiotics and lack of nutrition.
A reduction in mastication ability with less salivary function
and loss of dentition can limit the nutrient intake and, thus,
impact the microbial growth. Oropharyngeal and esophageal
motility are reduced with ageing resulting in swallowing
propulsions and lowered esophageal sphincter pressure, lead-
ing to an increased prevalence of gastroesophageal reflux.
With age, there is also an increased intestinal transit time due
to reduced motility, which can reduce digestion and absorp-
tion, andwith reduced appetite, thismay lead tomalnutrition
[7, 44]. In particular, hypochlorhydria is associated with
ageing and is prevalent in those who have or previously had
Helicobacter pylori infection.Hypochlorhydria predisposes to
malabsorption, alteration in bacterial growth, and vitamin
B12 deficiency leading to atrophic gastritis (autoimmune),
and loss of parietal cells.Malnutrition is one of the key factors
affecting the growth of gut microbiota and contributes to an
impaired immune system in the older adults.
2.5. Specific Gut Microbial Changes in the Older Adults.
A significant decrease in the relative proportions of Bac-
teroidetes and Firmicutes in the older adults, when compared
to adults, was observed in a study by Mariat et al. [18]
(Figure 1). Apart from these major two phyla, a decline in
Clostridium cluster IV was also observed in institutionalized
older individuals [45].The relationship between frailty scores
and diversity of themicrobiota in the older people was shown
in a study that involved 23 older volunteers and analysis
of their faecal samples [46]. A substantial decrease in Bac-
teroidetes, Prevotella, Lactobacillus, Candida albicans, Strep-
tococcus, Staphylococcus, and Faecalibacterium prausnitzii
and an increase in levels of Ruminococcus, Enterobacterium,
and Atopobium was reported [18, 46]. The relative variability
of gutmicrobiome among the older populationwasmeasured
and analyzed by Claesson et al. [45]. Faecal samples from
165 older people and 9 young (controls) volunteers were
collected and microbiota analysis was performed using 16S
ribosomal RNA (rRNA) gene sequencing technology. The
proportions of Bacteroidetes and Firmicutes in individuals
varied from 3% to 92% and 7% to 94%, respectively. A study
on the faecal bacteria in healthy old volunteers (age range
63 to 90 years; 𝑛 = 35) living in the local community, old,
hospitalized patients (age range 66 to 103 years; 𝑛 = 38), and
old, hospitalized patients receiving antibiotic treatment (age
range 65 to 100 years; 𝑛 = 21) [47] exhibited a decrease in
Bacteroides-Prevotella group in the old, hospitalized patients.
Another study investigated the age-related changes in the
gut microbiota and host immune system among young
adults (average 30 years), older adults (65 to 75 years), and
centenarians (99 to 103 years) using the Human Intestinal
Tract Chip and 16S rRNA gene sequencing methods [6].
Young adults and the older adult group showed a very com-
parable gut microbiota with Bacteroidetes and Firmicutes,
highly dominant, and small proportions of Proteobacteria
and Actinobacteria. In contrast, there were significantly
higher levels of Proteobacteria in the centenarian population,
relative changes in Firmicutes subgroups with a decrease in
Clostridium cluster IV, and an increase in Bacillus species.
The microbiota differences between adults and the older
adults in four different European countries (Italy, France,
Sweden, and Germany) were studied by [16] and found to be
country specific. Other studies also found differences in the
gut microbiota with respect to age, gender, and geographical
locations [16, 48].
Recent findings suggest that the gut microbial compo-
sition differs in men and women [36, 49]. Another study
compared gut microbiota of obese and lean men and women
(mean age of 60 years) with the same nutritional intake
[50]. This study revealed higher levels of Firmicutes in
women regardless of age and body mass index (BMI), and
men had lower levels of Bacteroidetes than women with
BMI over 33 kg/m2. The differences in the gut microbiota
between men and women may be influenced by the grade
of obesity and this could help in understanding the different
prevalence of metabolic and GI diseases between males
and females. The ELDERMET study by Claesson et al. [45]
compared the microbial composition of older and young
adults and found characteristic differences in Bacteroides and
Clostridium levels. There was greater variability in microbial
composition in the older people potentially contributing to
greater morbidities (Table 1).
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2.6. Metagenomic and Metabolic Changes Associated with Gut
Microbiota in Ageing. Mounting evidence indicates that gut
microbiota influences metabolism [51–53] and may play a
significant role in triggeringmetabolic diseases [54].The rela-
tionship between microbiota and metabolic and functional
pathways in the humans was investigated by The Human
Microbiome Project (HMP). From the HMP, it is known that
the humanmicrobiome is highly variable both within a single
subject and between different individuals. During the ageing
process, the host is challenged by various changes, including
diet and concomitant exposure to multiple medications,
including antibiotics, reduced physical activity, and/or any
underlying disease, which forces microbiome reshuffling to
adapt to the change [55].
A study investigated the functional differences between
the gut microbiome across age groups, including young
adults, older adults, and centenarians [6]. The study char-
acterized the metabolic trajectory of the gut microbiota
metagenome using illumina shotgun sequencing on 9 faecal
samples. It was found that proteolytic activity was increased
and there was a clear loss in the genes associated with the
metabolism of carbohydrates upon ageing. The capacity of
short chain fatty acids (SCFAs) production also declined
due to the age-related reduction of genetic pathways caused
by overall rearrangement of the microbiome. The data on
differential abundance in microbiome indicated structural
and functional changes in microbiota in the aged population,
moving from saccharolytic to a putrefactive metabolism.The
study also found that many shifts in the microbiome were
forcing rearrangements in the core metabolic potential of
the centenarians intestinal microbial ecosystem.This specific
microbiome analysis allows us to assess the role ofmicrobiota
in pathophysiological conditions in the older people cohort.
Manipulating the intestinal microbiota and microbiome
may be beneficial for maintaining health and treating certain
disorders, particularly common among the older individuals.
Nevertheless, more comprehensive clinical studies in differ-
ent age groups are required to fully understand the role of
microbiome in metabolism.
2.7. Circadian Rhythm, Microbiome, and Metabolism in Age-
ing. Circadian rhythm, metabolism, and gut microbiota are
intricately linked. A study compared human sleep-wake cycle
and insulin secretions and found robust variations in glucose
regulation during normal and no sleep conditions [56].
Most of the glucose tolerance occurs during sleep which
influences the nocturnal brain and tissue glucose utilization.
Therefore, chronic sleep disturbances and sleep apnea in the
older individuals may be linked to alterations in metabolism.
With reduced physiological function and sleep patterns, the
older adults may exhibit altered appetite leading to increased
susceptibility to GI and other metabolic disorders. Bass and
Turek [57] demonstrated the association between sleep-wake
cycle and metabolic regulation and suggested that interven-
tions in sleep disordersmay ameliorate some of themetabolic
deficits associated with overweight and obesity [57, 58].
Another study critically reviewed circadian rhythm, sleep,
and metabolism [59]. They suggested an association between
clock gene variations, obesity, and metabolic functions in
understanding the impact of circadian rhythm. Similarly,
a study demonstrated a bidirectional relationship between
circadian clock and metabolism, tested in a high fat diet
animal model [60]. A research scholar hypothesized that
the gut microbiota and microbiome are one of the key
elements in maintaining the circadian rhythm impacting
the dietary and physiological functions of the body [61]. To
test their hypothesis, they used germ-free mice and specific-
pathogen freemice.The study highlights the relation between
diet, gut microbial function, metabolome, and metabolic
function impacting the host health. The authors speculated
that any change in diet impacts the circadian rhythm and
manipulation in the gut microbial structure might restore
the metabolic balance. Age-related perturbations in gut
microbial structure and microbiome caused by diet and
other factors appear to affect the circadian clock, promoting
metabolic disorders and obesity. The relationship between
the gut microbiota and metabolism was first shown in germ-
free mice compared to conventional mice (both groups on
a high fat diet) [62]. Conventional mice gained weight (as
expected), whereas the germ-freemicemaintained their body
weight, suggesting an impaired feeding efficiency in the
germ-free mice. Studies by Turnbaugh et al. [62] confirm
this hypothesis, when germ-free mice gained weight when
colonized with the microbiota from obese rather than from
lean mice. The possible mechanism could be the activation
of the non-insulin dependent AMP-activated kinase pathway,
which controls energy expenditure via the increase in glucose
oxidation under metabolic stress conditions. Interestingly,
intestinal dysbiosis was observed in the obese leptin-deprived
ob/ob mice and it was subsequently shown that there was
microbial dysbiosis in obese humans when compared to
lean controls, suggesting a common mechanism in mice and
humans [51]. Therefore, gut microbiota can be considered
dependent on the host genome like observed in the ob/ob
mice. Importantly, the role of the gut microbiota in main-
taining homeostasis could also play a part in the microbial
genome [63].
3. Role of Gut Microbiota in Immune Function
in the Older Adults
3.1. Pro- and Anti-Inflammatory Responses. The gut asso-
ciated immune system is the largest component (approx-
imately 70%) of the human immune system [64]. Along
with numerous commensal bacteria, there are abundant
innate and adaptive immune cells in the gut (Figure 2).
Gut microbiota and the immune system actively interact to
maintain the homeostatic equilibrium [65]. This equilibrium
depends on the intestinal epithelial cells (IEC) in the colon
to segregate microbes andmucosal immune cells. Apart from
IECs, enterocytes and gut associated lymphoid tissue (GALT)
form a specialized barrier against invading pathogens. The
goblet cells of the IECs in the colon are capable of secreting
gel-like layers of mucus such as mucin and mucin 2 (MUC
2) which forms the first line of defense against the microbial
breach [66, 67]. Trefoil factor 3 (TFF3) and Resistin-like
molecule-𝛽 (RELM𝛽) are other goblet cell derived products
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fragilis), lipopolysaccharide (LPS), and AMPs (defensins, cathelicidins, and C-type lectins). IL-25, IL-33, and various growth related factors
help in the transformation of progenitor basophils to basophils, activation of monocytes, macrophages, and mast cells functioning. The
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as IL-10, which in turn helps with expansion of Treg cells which are already released during homeostasis and inflammation. Also with the
help of DCs, macrophages release certain B cell activating factors which increase the production of secretory immunoglobulin A (SIgA) to
maintain tolerance and steady state. (b) ((1) & (2)): in the elderly, there are declined physiological functioning and dysbiosis (reduction in
commensal bacteria), resulting in an increase in pathogens. (3)The production of IL-25, IL-33, and thymic stromal lymphopoietin (TSLP) by
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oxygen species (ROS) and causes oxidative stress. Altogether with reduced levels of Treg and T helper cells and SIgA increase the pathogen
invasion leading to release of proinflammatory cytokines and reduced anti-inflammatory cytokines increases inflammation, causing various
GI disorders.
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that contribute to forming a physical barrier in the intestine.
During inflammation, RELM𝛽 helps to secrete MUC 2 and
regulate macrophages and adaptive T cells [68]. Antimicro-
bial peptides (AMPs) secreted by enterocytes present in the
IEC further bolster the protective barrier. For example, in the
presence of B. thetaiotaomicron and L. innocua or stimulation
with lipopolysaccharide (LPS), the AMP levels were high in
the IECs [69]. Enterocytes also possess specialized pathogen
pattern recognition receptors (PPR) which contain Toll-like-
receptors (TLRs) and nucleotide oligomerization domain-
like-receptors (NOD), which recognize bacterial surface
molecular structures called microbe-associated molecular
patterns (MAMPs). MAMP recognition leads to activation of
an inflammatory response causing the release of nuclear fac-
tor kappa B (NF-kB) and tissue damage and NOD recognizes
the damage-associated molecular patterns (DAMPs) in the
host [70]. All the TLRs are present at the mRNA level of IEC
with different concentration levels. TLRs 2, 4, 5, and 9 detect
the presence of bacterial and fungal pathogens and TLRs 3, 7,
and 8 detect viral pathogens in the small and large intestine.
Microfolding (M) cells present in the subepithelial region
with lymphocytes and dendritic cells (DCs) at the base open
into the lamina propria (LP). M cells engulf pathogens by
phagocytosis or endocytosis and present the antigen (APCs)
toDCs. DCs, in the presence of a high number of interleukins
(IL-1𝛽, IL-6) and transforming growth factor (TGF-𝛽), which
unify the immune responses towards T helper (Th) 17 cells,
then trigger widespread inflammation by the release of
IL-17A, IL-17 F, IL-21, IL-22, and IL-23 [71]. Thus, DCs
trigger both pro- and anti-inflammatory responses in the
host.
3.2. Role of Enterocytes. Microorganisms are generally
located on the outer mucosal layer of the epithelium in a
compartmentalized fashion in the lumen. In order to reduce
the interaction of microbiota and enterocytes, there is a
dense gel-like inner layer on top of the epithelium secreted
by goblet cells (MUC 2) which is devoid of microbes where
in contrast the outer layer is thin and colonized with bacteria
[72]. Enterocytes sense the presence of microbes within
the mucus layers and monitor their proximity and density.
Thus, enterocytes act as the frontline in the microbiota-
immune cells crosstalk that occurs in the host. In healthy
ageing, enterocytes monitor GALT immune response, send
tolerance signals towards commensals, and keep DCs in
a stable mode [73]. M cells (APCs) present the antigen to
naı¨ve CD4+ cells, causing their differentiation into CD4+
T cells (T-regulatory), which elicit an anti-inflammatory
response (IL-10, TNF-𝛼). Concurrently, the antigens are also
presented to B cells in LP, stimulating the differentiation
of immunoglobulin A (IgA). IgA helps in neutralizing the
toxins produced by microbes and prevents the adherence
of the microbiota and the intestinal lumen. Secretory IgA
(SIgA) induction appears more efficient in the presence of
Bacteroidetes [74].
In the older adults, the preclinical and clinical studies
indicate a decline in immune function [65, 75, 76]. In aged
IEC (GALT and enterocytes), impairment and changes in
immune functions have been observed in animal models
[72]. With GALT impairment, there is a reduction in mucin
and defensins (𝛼-defensins and 𝛽-defensins) leading to an
increased chance of infection by uncontrolled growth of
commensals (mutualistic to opportunistic) and pathogens.
When there is an increase in pathogens, enterocytes could
possibly activate certain cytokines and chemokines forcing
DCs to initiate proinflammatory response by differentiation
of Th-1, Th-2, and Th-17 (effector) cells [77]. A study by [78]
demonstrated that Bacteroides fragilis releases polysaccharide
A (PSA) recognized by TLR and induces production of IL-10
by Treg cells (in the presence of TGF-𝛽). Induction of Treg
cells is not restricted to Bacteroides fragilis, as the presence
of an indigenous Clostridium species also promotes Treg
cell activation. A study [79] showed the role of clostridia in
inducing Treg cells in germ-free mice. A total of 17 strains
from Clostridiales clusters VI, XIVa, and XVIII isolated from
human faeces exhibited Treg-inducing activity, suggesting
that Clostridium-dependent induction of Tregs may con-
tribute to the maintenance of intestinal immune homeostasis
[21]. A change to the Bacteroides-Firmicutes group triggers
the release of IL-6 by DCs in the LP and activates na¨ıve
T cells. Naı¨ve T (T0) cells differentiate into Th-17 and Th-
1 cells, which are responsible for inflammation in colitis
[80].
3.3. Short Chain Fatty Acids (SCFAs). Gut microbiota gen-
erate a range of metabolites, particularly SCFAs such as
butyrate, propionate, and acetate. These SCFAs are linked
to the elicitation of anti-inflammatory and antineoplastic
responses via inhibition of NF-kB favoring growth of the
intestinal epithelium [81]. Butyrate is considered the primary
source of energy to the intestinal epithelium and helps in
the production of mucin (gel-like inner layer) in the lumen
which establishes the physical barrier. Deficiency of SFCA
leads to epithelial atrophy and inflammation during colitis
[82]. In the older adults, the decline in butyrate levels is cor-
related to a decrease in F. prausnitzii, Eubacterium hallii, and
Eubacterium rectal [6]. Also, due to the decline in butyrate
and weakened physical barrier, the immunologic tolerance
decreases, allowing the increase in Enterobacteriaceae in the
older adults. This was corroborated in a study conducted by
[6], where proinflammatory cytokine levels increased and
were related to inflamm-ageing. Additionally, reduction in
proinflammatory responses and decline in SCFA levels have
been linked to risk of colorectal cancers [83, 84].
3.4. Sex Related Differences. Both the immune and the
endocrine system exhibit significant sex-specific differences.
A transcriptome study onperipheral bloodmononuclear cells
revealed lower T cell responses and more inflammation in
older females [85]. Another study from Japan on an ageing
population indicated progression of immunosenescence in
older men with a decline in T cell proliferation when com-
pared to olderwomen [86]. Age-related changes in sex steroid
levels enhance immunosenescence-related alterations. It is
also shown that gut microbial and sex hormone differences
with ageing may lead to autoimmune diseases in animal
models [87]. The association of sex differences, ageing, and
immune response with gutmicrobiota was critically reviewed
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by [86]. The authors emphasized that early exposure to envi-
ronment influences microbiome and sex-dependent immune
responses and suggested that sex should be considered as a
biological variable in immunological studies.
3.5. Dietary Influences. Due to reduced immune activity,
the older adult population are generally categorized as
immunocompromised as their resistance towards infections
is lowered. The link between microbiota and the immune
system can be demonstrated by examining the effects of
the administration of various dietary supplements such
as prebiotics, probiotics, and synbiotics (Table 2). Dietary
supplementation of a probiotic drink with Bacillus subtilis
at a rate of 2 × 109 colony forming units (CFU) for 18 days
(𝑛 = 44) increased the levels of SIgA by 65% in the stools and
saliva during common cold infections in the older adults [88].
Consumption of a probiotic drink containing L. casei Shirota
(LcS) at 1.3 × 1010 CFU for 4 weeks increased natural killer
(NK) cell activity and significantly decreased intensity of
CD25 in T resting cells in healthy non-immunocompromised
older people [89, 90]. Prebiotics such as a bifidogenic growth
stimulator and galactooligosaccharide when consumed with
fermented milk for 4 weeks improved and maintained anti-
body titers for longer periods through improving intestinal
microbiota in the older adults with influenza vaccination [91].
Similarly, in a randomized, double-blind study conducted on
43 older people, supplementation of a synbiotic (containing
probiotic Bifidobacterium longum and an inulin-based pre-
biotic synergy 1) for 4-weeks increased the bifidobacterial
count and also increased the counts of Actinobacteria and
Firmicutes. Proteobacteria were reduced by 1.0 log units.
Therewas reduction of proinflammatory cytokineTNF-𝛼 and
an increase in butyrate production [75]. Therefore, dietary
supplementation with pre/pro/synbiotics in the older adults
not only increases the intestinal commensal diversity but also
reinforces the immune system against various pathological
conditions.
4. Modulation of Gut Microbiota for Health
As discussed in the earlier sections, diet plays an important
role during the establishment and development of stable
gut microbiota and can assist in its modulation. Due to
the high prevalence of malnutrition in the older adults,
dietary manipulation may play an important role. There is a
decline in SCFA production in the older adult’s gut due to a
major shift in bacterial composition andmalnutrition.This in
turn contributes to a decline in anti-inflammatory response
leading to an increase in infections. A high-fibre diet is widely
recommended for adults and the older adults as it increases
the SCFA production and decreases the intestinal pH, reduc-
ing the colonization of pathogenic bacteria. However, high
fat diets with certain cooking oils containing polyunsatu-
rated fatty acids (omega-3-PUFA) increased the levels of
Firmicutes and Actinobacteria and decrease Bacteroidetes
[91].
Many specific therapies have been proposed for treating
dysbiosis, such as the use of prebiotics, probiotics, and
synbiotics. A number of clinical studies demonstrated the
ability of probiotics (most used are Lactobacillus, Bifidobac-
terium, Lactococcus, and Streptococcus) inmodulating the gut
bacteria in infants, adults, and the older adults [21, 92, 93].
These studies indicated an increase of SCFA production and
improvement of the immune system [30]. Prebiotics alone
were shown to improve the gut microbiota and help in
production of SCFA [94].
Broad spectrum antibiotic therapy successfully treats
many infections, however, at the expense of commensal
bacterial loss. In all ages, careful use of antibiotics is preferred
and when used, the potential use of narrow spectrum or
targeted therapy is preferred, as this reduces microbiota
alteration.
The concept of faecal microbiota transplantation (FMT)
was introduced to control recurrent infections. FMT can
be defined as a nature-tailored probiotic to control recur-
rent infections. Basically, a faecal sample from a healthy
donor is selected and infused into the diseased patients via
colonoscopy, endoscopy, sigmoidoscopy, or enema [95]. FMT
produced 90% benefit as a treatment option for diarrhea due
to recurrent C. difficile infection. In 2013 the United States
Food and Drug Administration categorized faecal samples
as a biological, investigational tool for the purpose of a
therapeutic agent [93]. Many researchers have shown the
effectiveness of FMT in IBD, Crohn’s diseases, and ulcerative
colitis, but important aspects of this treatment such as the
screening and selection of healthy donors are still to be
defined. FMT could also possibly be used against H. pylori
infection (which may cause ulcers and gastric cancers), to
minimize the effects of antibiotic use, particularly in the older
adult population [96].
5. Conclusion
Gut microbial diversity declines with age and its function
in metabolism and regulation of the immune system is
reduced. This provides a chance for opportunistic pathogens
to invade and inflame the gut giving rise to various diseases
ranging from low-grade chronic ill health to those causing
hospitalization and even death. Despite significant research
on gut microbiota, the optimal therapy to reduce/prevent
the dysbiosis in the older adults is yet to be identified.
Diet plays a role as a manipulator of the gut microbiota
throughout life and this may be particularly important in the
older adults. The use of broad spectrum antibiotics almost
certainly has an adverse effect on gut bacteria. We believe
probiotic supplementation has significant potential to restore
the diversity of the gut microbiota and improve immune
function. However the specifics of supplementation, dosage
and other parameters are still unclear. More well-conducted
randomized studies on probiotics/prebiotics/synbiotics in the
older adults are needed.
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